Figure 3From: The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in SwedenCost-effectiveness ratios per QOL- AGDHA group and men and women. Each graph shows the cost-effectiveness ratio (vertical axis) as a function of the QOL-AGDHA score (horisontal axis).Back to article page